PFO
Pathstone Family Office’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $1.82M | Buy |
14,845
+9,557
| +181% | +$1.17M | 0.01% | 486 |
|
2023
Q2 | $671K | Buy |
+5,288
| New | +$671K | 0.01% | 623 |
|
2022
Q4 | – | Sell |
-6,742
| Closed | -$789K | – | 1524 |
|
2022
Q3 | $789K | Buy |
+6,742
| New | +$789K | 0.01% | 862 |
|
2021
Q1 | – | Sell |
-312
| Closed | -$47K | – | 950 |
|
2020
Q4 | $47K | Buy |
+312
| New | +$47K | ﹤0.01% | 519 |
|
2020
Q3 | – | Sell |
-290
| Closed | -$40K | – | 898 |
|
2020
Q2 | $40K | Hold |
290
| – | – | ﹤0.01% | 342 |
|
2020
Q1 | $31K | Hold |
290
| – | – | ﹤0.01% | 366 |
|
2019
Q4 | $349K | Buy |
+290
| New | +$349K | ﹤0.01% | 340 |
|
2015
Q4 | – | Sell |
-15
| Closed | -$5K | – | 126 |
|
2015
Q3 | $5K | Buy |
+15
| New | +$5K | 0.01% | 124 |
|
2013
Q4 | – | Sell |
-75
| Closed | -$16K | – | 257 |
|
2013
Q3 | $16K | Buy |
+75
| New | +$16K | 0.07% | 144 |
|